CMS advised Tubulis on the deal, Baker McKenzie advised Andera Partners, Evotec and Fund+ on the deal. Biotech company Tubulis has successfully completed a Series B...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here